Ask VialBase
Neuroprotection: IV complex vs intranasal peptide

Cerebrolysin vs Semax

Comparing Cerebrolysin and Semax across evidence, dosing, mechanisms, and research areas.

vs
Category
cognitive
cognitive
Molecular weight
—
813.93 g/mol
Half-life
—
~30 minutes (intranasal)
Admin routes
—
intranasalsubcutaneous
Research areas
—
Cognitive enhancementNeuroprotectionStroke recoveryADHDAlzheimer's diseaseSpinal cord injury
Typical dosing
—
200–600 mcg · 1-2x daily · 2-4 weeks on, 2 weeks off
FDA status
not-FDA-approved
Not FDA-approved. Approved in Russia since 2011 for stroke, cognitive disorders, and peptic ulcers
WADA status
—
Not listed
PubMed studies
—
204

More Comparisons

bpc-157 vs tb-500 cjc-1295 vs ipamorelin semaglutide vs tirzepatide ghk-cu vs ghk ghrp-2 vs ghrp-6 igf-1-lr3 vs igf-1-des semax vs selank epithalon vs ghk-cu bpc-157 vs ghk-cu pt-141 vs kisspeptin semaglutide vs aod-9604 tirzepatide vs mk-677 bpc-157 vs cerebrolysin tesamorelin vs cjc-1295 mk-677 vs ipamorelin thymosin-alpha-1 vs ll-37 mots-c vs nad-plus epithalon vs nad-plus semaglutide vs retatrutide

This comparison is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before using any peptide or supplement.

Source this stack
Cerebrolysin1 vetted vendor
Certified-PepVisit Certified-Pep →
See all 1 source →
Semax11 vetted vendors
BioLongevity LabsVisit BioLongevity Labs →

Save 15% with code VIALBASE

See all 11 sources →

VialBase may earn a commission on partner links — never at extra cost to you. Disclosure.